Your browser doesn't support javascript.
loading
Characterizing asparagine synthetase deficiency variants in lymphoblastoid cell lines.
Staklinski, Stephen J; Chang, Mario C; Ahrens-Nicklas, Rebecca C; Kaur, Shagun; Stefanatos, Arianna K; Dudenhausen, Elizabeth E; Merritt, Matthew E; Kilberg, Michael S.
Affiliation
  • Staklinski SJ; Department of Biochemistry and Molecular Biology University of Florida College of Medicine Gainesville Florida USA.
  • Chang MC; School of Biological Sciences Cold Spring Harbor Laboratory, Cold Spring Harbor New York New York USA.
  • Ahrens-Nicklas RC; Department of Biochemistry and Molecular Biology University of Florida College of Medicine Gainesville Florida USA.
  • Kaur S; Division of Human Genetics, Department of Pediatrics Children's Hospital of Philadelphia Philadelphia Pennsylvania USA.
  • Stefanatos AK; Division of Human Genetics, Department of Pediatrics Children's Hospital of Philadelphia Philadelphia Pennsylvania USA.
  • Dudenhausen EE; Department of Child and Adolescent Psychiatry and Behavioral Sciences Children's Hospital of Philadelphia Philadelphia Pennsylvania USA.
  • Merritt ME; Department of Biochemistry and Molecular Biology University of Florida College of Medicine Gainesville Florida USA.
  • Kilberg MS; Department of Biochemistry and Molecular Biology University of Florida College of Medicine Gainesville Florida USA.
JIMD Rep ; 64(2): 167-179, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36873094
ABSTRACT
Asparagine synthetase (ASNS) catalyzes the synthesis of asparagine (Asn) from aspartate and glutamine. Biallelic mutations in the ASNS gene result in ASNS Deficiency (ASNSD). Children with ASNSD exhibit congenital microcephaly, epileptic-like seizures, and continued brain atrophy, often leading to premature mortality. This report describes a 4-year-old male with global developmental delay and seizures with two novel mutations in the ASNS gene, c.614A > C (maternal) and c.1192dupT (paternal) encoding p.H205P and p.Y398Lfs*4 variants, respectively. We employed the novel use of immortalized lymphoblastoid cell lines (LCL) to show that the proliferation of the heterozygotic parental LCL was not severely affected by culture in Asn-free medium, but growth of the child's cells was suppressed by about 50%. Asn production by the LCL from both the father and the child was significantly decreased relative to the mother's cells. mRNA and protein analysis of the paternal LCL cells for the Y398Lfs*4 variant revealed reductions in both. Attempts to ectopically express the truncated Y398Lfs*4 variant in either HEK293T or ASNS-null cells resulted in little or no detectable protein. Expression and purification of the H205P variant from HEK293T cells revealed enzymatic activity similar to wild-type ASNS. Stable expression of WT ASNS rescued the growth of ASNS-null JRS cells in Asn-free medium and the H205P variant was only slightly less effective. However, the Y398Lfs*4 variant appeared to be unstable in JRS cells. These results indicate that co-expression of the H205P and Y398Lfs*4 variants leads to a significant reduction in Asn synthesis and cellular growth.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JIMD Rep Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JIMD Rep Year: 2023 Document type: Article